Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA® ?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)
CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who…
CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who…
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Acquisition--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:…
This award spotlights successful and innovative transformation projects that deliver bottom-line value to small, medium,…
Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia--(BUSINESS…
Transaction Expected to Close on July 6, 2022 BILLERICA, Mass. & AURORA, Ill.--(BUSINESS WIRE)--Entegris, Inc.…
Acumen Research and Consulting recently published report titled “mTOR Inhibitors Market Size, Share, Analysis Report…
Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced.…
Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced.…
DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been…
DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been…